FDA Peptide Reclassification 2026: What It Means for Providers Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law How did BPC 157 become the wellness industry's star peptide? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York